ArthurYu ShinKimMD

Assistant Professor of Medicine, Massachusetts General Hospital

Dr. Kim is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
55 Fruit St
Cox 5
Boston, MA 02114
Phone+1 617-726-3906

Fax+1 617-726-7653

Massachusetts General Hospital/Brigham and Women's Hospital/Harvard Medical SchoolFellowship, Infectious Disease, 2000 - 2003
Massachusetts General HospitalResidency, Internal Medicine, 1997 - 2000
Harvard Medical SchoolClass of 1997

PubMed

Patient-navigator working alliance and hepatitis C treatment cascade outcomes among persons who inject drugs: The HERO study.
Snehal S Lopes, J Edward Dotherow, Irene Pericot-Valverde, Paula J Lum, Lynn E Taylor
Drug and Alcohol Dependence. 2025-05-01
Improvement in anxiety symptoms during treatment of Hepatitis C in people who inject drugs: The HERO study.
Jessica Obeysekare, Irene Pericot-Valverde, Snehal Lopes, Megan Groome, Brianna L Norton
Drug and Alcohol Dependence. 2025-05-01
Severe outcomes of COVID-19 among adults with increased risk conditions: A population-based observational study.
Scott Dryden-Peterson, Andy Kim, Ellen C Caniglia, Mary-Ruth Joyce, David Rubins
Plos One. 2025-01-01

Journal Articles

Efficacy of Tocilizumab in Patients Hospitalized with Covid-19
Naomi J Serling-Boyd, Ann E Woolley, Manish Sagar, Harry Schrager, David S Huckins, Jorge Fleisher, Rachel S Wallwork, Arthur Y Kim, Pritha Sen, Eric Meyerowitz, Megan..., The New England Journal of Medicine
Efficacy of Tocilizumab in Patients Hospitalized with Covid-19
Naomi J Serling-Boyd, Ann E Woolley, Manish Sagar, Harry Schrager, Jorge Fleisher, Rachel S Wallwork, Arthur Y Kim, Pritha Sen, Eric Meyerowitz, Megan M Lockwood, Mich..., The New England Journal of Medicine
Efficacy of Tocilizumab in Patients Hospitalized with Covid-19
Naomi J Serling-Boyd, Ann E Woolley, Manish Sagar, Harry Schrager, Jorge Fleisher, Rachel S Wallwork, Arthur Y Kim, Pritha Sen, Eric Meyerowitz, Megan M Lockwood, Mich..., The New England Journal of Medicine
Management of Hepatitis A in 2020-2021
Angel N Desai, Arthur Y Kim, JAMA
Join now to see all

We Have a Cure for Hepatitis C. Why Are Hundreds of New Englanders Still Dying Every Year?November 29th, 2022
The Monoclonal Antibodies Strike Back: New Data on Their Use in COVID-19September 14th, 2021
7 Lessons We've Learned from This Pandemic to Remember for the Next OneJune 11th, 2021
Join now to see all

Discovery And Assessment Of Genetic Determinants Of HCV And HIV ControlNational Institute On Drug Abuse2011
Acute HCV In The Prison PopulationNational Institute Of Allergy And Infectious Diseases2010–2011
Discovery And Assessment Of Genetic Determinants Of HCV And HIV ControlNational Institute Of Allergy And Infectious Diseases2010
Acute Hepatitis C Virus Infection In The Prison PopulationNational Institute Of Allergy And Infectious Diseases2007–2009
Cell Mediated Immunity To HCV In HIV+ PersonsNational Institute Of Allergy And Infectious Diseases2003–2007
Acute HCV Infection In The Prison PopulationNational Institute Of Allergy And Infectious Diseases2005–2006
Cell-Mediated Immunity To HCV In HIV+ PersonsNational Institute Of Allergy And Infectious Diseases2004–2006